Morgan Stanley »

Alaunos Therapeutics Inc - US shares owned by Morgan Stanley

Quarter-by-quarter ownership of Alaunos Therapeutics Inc - US (TCRT) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Alaunos Therapeutics Inc - US

Tip: Access up to 7 years of quarterly data

All positions including Alaunos Therapeutics Inc - US held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alaunos Therapeutics Inc - US by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $31k 17k 1.81

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Alaunos Therapeutics Inc - US

MSDC Management
Vanguard Group
BlackRock
Geode Capital Management
Citadel Advisors
Advisor Group Holdings
Commerce Bank N A
Northern Trust
Magnolia Capital Advisors
Morgan Stanley
Allred Capital Management
UBS Group
Virtu Financial
Atlantic Trust
Fortis Group Advisors

View all funds holding Alaunos Therapeutics Inc - US